Eli Lilly's Gene Editing Therapy Shows Promise in Lowering Cholesterol
Eli Lilly has announced encouraging results from a recent clinical trial of its gene-editing therapy, indicating a significant reduction in cholesterol levels among participants.
Editorial Staff Updated 18 days ago